JP5823986B2 - 脂肪移植物の生存を増大させるための方法及び組成物 - Google Patents

脂肪移植物の生存を増大させるための方法及び組成物 Download PDF

Info

Publication number
JP5823986B2
JP5823986B2 JP2012554466A JP2012554466A JP5823986B2 JP 5823986 B2 JP5823986 B2 JP 5823986B2 JP 2012554466 A JP2012554466 A JP 2012554466A JP 2012554466 A JP2012554466 A JP 2012554466A JP 5823986 B2 JP5823986 B2 JP 5823986B2
Authority
JP
Japan
Prior art keywords
fat
epo
erythropoietin
adipocytes
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012554466A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520271A5 (enExample
JP2013520271A (ja
Inventor
サヘル ハメド，
サヘル ハメド，
Original Assignee
セバナ メディカル リミテッド
セバナ メディカル リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セバナ メディカル リミテッド, セバナ メディカル リミテッド filed Critical セバナ メディカル リミテッド
Publication of JP2013520271A publication Critical patent/JP2013520271A/ja
Publication of JP2013520271A5 publication Critical patent/JP2013520271A5/ja
Application granted granted Critical
Publication of JP5823986B2 publication Critical patent/JP5823986B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
JP2012554466A 2010-02-23 2011-02-23 脂肪移植物の生存を増大させるための方法及び組成物 Active JP5823986B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30699110P 2010-02-23 2010-02-23
US61/306,991 2010-02-23
PCT/IL2011/000181 WO2011104707A1 (en) 2010-02-23 2011-02-23 Methods and compositions for enhancing fat graft survival

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015200614A Division JP6023864B2 (ja) 2010-02-23 2015-10-08 脂肪移植物の生存を増大させるための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2013520271A JP2013520271A (ja) 2013-06-06
JP2013520271A5 JP2013520271A5 (enExample) 2014-04-10
JP5823986B2 true JP5823986B2 (ja) 2015-11-25

Family

ID=44506187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012554466A Active JP5823986B2 (ja) 2010-02-23 2011-02-23 脂肪移植物の生存を増大させるための方法及び組成物
JP2015200614A Active JP6023864B2 (ja) 2010-02-23 2015-10-08 脂肪移植物の生存を増大させるための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015200614A Active JP6023864B2 (ja) 2010-02-23 2015-10-08 脂肪移植物の生存を増大させるための方法及び組成物

Country Status (12)

Country Link
US (1) US20120315254A1 (enExample)
EP (1) EP2539443B1 (enExample)
JP (2) JP5823986B2 (enExample)
CN (1) CN102906250A (enExample)
AU (1) AU2011219425A1 (enExample)
BR (1) BR112012021179A2 (enExample)
CA (1) CA2790867A1 (enExample)
IL (1) IL221619A (enExample)
IN (1) IN2012MN02218A (enExample)
MX (1) MX2012009768A (enExample)
RU (1) RU2012140379A (enExample)
WO (1) WO2011104707A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016041261A (ja) * 2010-02-23 2016-03-31 セバナ メディカル リミテッド 脂肪移植物の生存を増大させるための方法及び組成物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5953035B2 (ja) * 2011-11-28 2016-07-13 学校法人慶應義塾 病理診断支援装置、病理診断支援方法、及び病理診断支援プログラム
CN107456606A (zh) * 2017-08-30 2017-12-12 上海新肌生物科技有限公司 一种脂肪细胞存活率提高91%的复活素配方及制备方法
CN110229785A (zh) * 2019-06-17 2019-09-13 白晋 一种利用血管内皮祖细胞提升脂肪移植成功率的方法
CN111548988B (zh) * 2020-05-14 2023-06-20 江苏芝海生物科技有限公司 一种医用漂洗液及其制备方法和应用
CA3200227A1 (en) * 2020-11-25 2022-06-02 Alexandra Sophie DE BOER Adipogenic cell compositions and methods
CN113413177B (zh) * 2021-06-23 2022-08-02 美闺(长沙)医疗美容有限公司 一种保持自体脂肪活性的移植设备及控制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7459152B2 (en) * 2003-04-23 2008-12-02 Rush University Medical Center Erythropoietin administration to improve graft survival
BRPI0411621A (pt) * 2003-06-18 2006-08-08 Macropore Biosurgery Inc métodos de uso de células derivados de tecido adiposo no aumento de transferência de gordura autóloga
PT1699915E (pt) * 2003-12-30 2010-08-31 Augustinus Bader Utilização de eritropoietina para a regeneração de tecido hepático
ITPD20050168A1 (it) * 2005-06-01 2006-12-02 Fidia Advanced Biopolymers Srl Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
JP5039715B2 (ja) * 2006-01-24 2012-10-03 ブラウン ユニバーシティ 細胞凝集及び封入デバイス及び方法
WO2008019434A1 (en) 2006-08-14 2008-02-21 Victorian Tissue Engineering Pty Ltd The use of growth factors in a method of improving fat-graft survival
EP2192907B1 (en) * 2007-08-16 2018-04-18 Remedor Biomed Ltd. Erythropoietin and fibronectin compositions for therapeutic applications
AU2011219425A1 (en) * 2010-02-23 2012-10-18 Sebana Medical Ltd. Methods and compositions for enhancing fat graft survival

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016041261A (ja) * 2010-02-23 2016-03-31 セバナ メディカル リミテッド 脂肪移植物の生存を増大させるための方法及び組成物

Also Published As

Publication number Publication date
EP2539443A4 (en) 2013-12-11
RU2012140379A (ru) 2014-03-27
US20120315254A1 (en) 2012-12-13
EP2539443B1 (en) 2019-03-27
BR112012021179A2 (pt) 2015-09-15
IN2012MN02218A (enExample) 2015-06-12
JP6023864B2 (ja) 2016-11-09
IL221619A (en) 2017-09-28
AU2011219425A1 (en) 2012-10-18
EP2539443A1 (en) 2013-01-02
CA2790867A1 (en) 2011-09-01
CN102906250A (zh) 2013-01-30
MX2012009768A (es) 2013-02-27
JP2013520271A (ja) 2013-06-06
JP2016041261A (ja) 2016-03-31
WO2011104707A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
JP6023864B2 (ja) 脂肪移植物の生存を増大させるための方法及び組成物
Li et al. Dental pulp stem cell‐derived exosomes alleviate cerebral ischaemia‐reperfusion injury through suppressing inflammatory response
Zhang et al. Exosomes derived from platelet-rich plasma administration in site mediate cartilage protection in subtalar osteoarthritis
Kaisang et al. Adipose-derived stem cells seeded in Pluronic F-127 hydrogel promotes diabetic wound healing
EP4047083A1 (en) Pluripotent stem cell, pharmaceutical composition, and preparation method therefor and application thereof
US8507431B2 (en) Methods for accelerating wound healing by administration of a preadipocyte modulator or an adipocyte modulator
Hu et al. Combination of mesenchymal stem cell-conditioned medium and botulinum toxin type A for treating human hypertrophic scars
Shen et al. 6-Bromoindirubin-3′-oxime promotes osteogenic differentiation of periodontal ligament stem cells and facilitates bone regeneration in a mouse periodontitis model
Choi et al. Enhanced tissue remodelling efficacy of adipose‐derived mesenchymal stem cells using injectable matrices in radiation‐damaged salivary gland model
Sheng et al. Sodium alginate/gelatin hydrogels loaded with adipose‐derived mesenchymal stem cells promote wound healing in diabetic rats
CN105377275A (zh) 用于静脉给药的干细胞组合物
You et al. Nanosilver alleviates foreign body reaction and facilitates wound repair by regulating macrophage polarization
US20140242043A1 (en) Methods for preventing or treating optic neuritis
EP3921029B1 (en) Composition comprising ccl5 for use in treating bone break, bone fracture, bone degeneration and osteoporosis
US20250018088A1 (en) Compositions and methods for repairing damage to skeletal muscle
WO2012025925A1 (en) Methods of improving transplantation using sdf-1alpha
US20160324928A1 (en) Methods for treating blepharitis
KR20250037691A (ko) 중간엽 줄기세포 스페로이드, 이의 제조방법 및 이를 포함하는 조성물
KR20160000030A (ko) 피부 또는 혈관조직 손상 치료 보조용 약학 조성물
Cheng et al. A new function of a previously isolated compound that stimulates activation and differentiation of myogenic precursor cells leading to efficient myofiber regeneration and muscle repair
Zhang et al. Platelet-rich plasma-derived exosomes have the novel ability to alleviate insertional Achilles tendinopathy by promoting tenogenesis in tendon stem/progenitor cells
El-Qashty et al. The role of erythropoietin-loaded hydrogel versus adipose derived stem cell secretome in the regeneration of tongue defects
Sukpat et al. A low dose of simvastatin enhanced the therapeutic efficacy of mesenchymal stem cell (MSC) transplantation in skin wound healing in diabetic mice associated with increases in pAkt, SDF-1, and angiogenesis
RU2790031C2 (ru) Способ лечения аллергического заболевания дыхательных путей (AAD)/астмы
Song et al. A temperature responsive hydrogel encapsulated with adipose‐derived stem cells and melanin promotes repair and regeneration of endometrial injury

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140219

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20150113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150113

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150519

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150908

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151008

R150 Certificate of patent or registration of utility model

Ref document number: 5823986

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250